Endrisone
Chemical compound
 | |
| Clinical data | |
|---|---|
| Trade names | Aldrisone |
| Other names | Delta-medrysone;[1] 6α-Methyl-11β-hydroxypregna-1,4-diene-3,20-dione; 6α-Methyl-11β-hydroxy-Δ1-progesterone |
| Routes of administration | Topical, ophthalmic[1][2] |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID |
|
| ChemSpider |
|
| UNII |
|
| KEGG |
|
| ChEMBL |
|
| ECHA InfoCard | 100.047.587  |
| Chemical and physical data | |
| Formula | C22H30O3 |
| Molar mass | 342.479 g·mol−1 |
| 3D model (JSmol) |
|
| |
InChI
| |
Endrisone (INN) (brand name Aldrisone), or endrysone (USAN), is a synthetic, steroidal glucocorticoid which is or has been marketed in Italy by SIFI.[1][2][3] It is used as a topical and ophthalmic anti-inflammatory drug in the treatment of skin and eye conditions, respectively.[1][2]
See also
References
- ^ a b c d Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 486–. ISBN 978-1-4757-2085-3.
- ^ a b c Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 110–. ISBN 978-94-011-4439-1.
- ^ Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 386–. ISBN 978-3-88763-075-1.
- v
- t
- e
- Antagonists: Aglepristone
- Ketoconazole
- Mifepristone
- Ulipristal acetate
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
- See also
- Glucocorticoid receptor modulators
- Mineralocorticoids and antimineralocorticoids
- List of corticosteroids
 | This article about a steroid is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
